Articles related to NURSING

The author explains that a nursing strike can have a significant impact on oncology practices, which rely heavily on nursing staff for patient care. The article suggests that practices should have a contingency plan in place in the event of a strike, including identifying alternative sources of nursing staff, communicating with patients about the potential impact on their care, and ensuring that all staff members are trained on how to handle the situation. The article also emphasizes the importance of maintaining a respectful and open dialogue with nursing staff throughout the negotiation process to minimize the likelihood of a strike.

The US Bureau of Labor Statistics released job growth projections for the next decade, from 2021 to 2031. Nurse practitioners are expected to grow at a rate of 45% across all industries. Over the next ten years, the number of employed nurse practitioners is expected to increase from 246,700 to 359,400. Sadly, physicians are missing from the list, with the Association of American Medical Colleges projecting a shortage of 37,800 to 124,000 physicians by the year 2034.

Lack of Concordance Between Radiologic and Pathologic Responses in Neoadjuvant ICI Treatment of Melanoma: How Do I Assess Radiologic Progression? After taking part in this CME activity, medical oncologists, surgeons, dermatologists, oncology nurses, oncology pharmacists, and other members of the interprofessional team who manage patients with melanoma should be better able to:

Hematologist-oncologists, hematology-oncology NP/PAs, hematology-oncology nurses, and pharmacists should be better able to use criteria for erythroid-stimulating agent (ESA) failure to hasten the identification of patients with lower-risk myelodysplastic syndrome (MDS) refractory to ESA therapy, integrate safety and efficacy data on emerging therapeutic options into treatment planning for patients with lower-risk MDS after ESA failure, and integrate a multidisciplinary treatment approach after taking part in this CME activity.

Researchers examined the OTC drug shopping patterns of 153 women before being diagnosed with ovarian cancer and compared them to the patterns seen in 120 women without ovarian cancer. Participants in the study also answered questions regarding the symptoms they had and the number of times they had seen their general practitioner in the year preceding a cancer referral or diagnosis. Eight months before diagnosis, there was a substantial difference in the OTC drug buying habits of women with and without ovarian cancer. Up to nine months prior to diagnosis, there was a rise in the purchasing of dyspepsia medications.

HER2-Directed ADCs in Gastric Cancer Several antibody-drug conjugates (ADCs) have recently received approval for use in treating a range of solid cancers. This poses difficulties when handling a variety of adverse treatment-related events, some of which can take practitioners into uncharted area. After viewing this CME activity, medical oncologists, pulmonologists, urologists, pathologists, oncology NPs, PAs, oncology nurses, oncology pharmacists, and other HCPs caring for patients with solid tumors should be able to describe the elements of an antibody-drug conjugate (ADC) that may cause adverse events (AEs), identify AEs that result in treatment interruption or discontinuation, and suggest a strategy for managing the key AEs.